Bay Area biotech company Synthego, raised $392M, forced into bankruptcy
by duxup on 5/19/2025, 11:45:25 PM
Biotech seems to historically require a lot of iterations / failures before breakthroughs happen.
I'm not sure the typical VC "startup" type expectations / speed really lends itself to that kind of business.
by hoseyor on 5/19/2025, 11:35:24 PM
I wonder if that was private lending/credit. There seems to be a huge issue building in that unregulated space.
Biotech seems to historically require a lot of iterations / failures before breakthroughs happen.
I'm not sure the typical VC "startup" type expectations / speed really lends itself to that kind of business.